Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Paris France (2011)

Organization Overview

First Clinical Trial
2011
NCT01828736
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Marrow Diseases (Phase 2)

Bone Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Kidney Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 2)

Prostatic Neoplasms (Phase 3)

Urinary Bladder Neoplasms (Phase 2)

von Hippel-Lindau Disease (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 21